2021
DOI: 10.3389/fdgth.2021.633427 View full text |Buy / Rent full text
|
|

Abstract: “Real-world evidence (RWE)” is becoming increasingly important in order to integrate the results of randomized studies into everyday clinical practice. The data collection of RWE is usually derived from large-scale national and international registries, often driven by academic centers. We have developed a digitalized doctor–patient platform called DESTINY (DatabasE-assiSted Therapy decIsioN support sYstem) that is utilized by NeuroTransData (NTD), a network of neurologists and psychiatrists throughout Germany… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
2
0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

0
2
0
Order By: Relevance
“…Because PHREND® is based on data extracted from the routinely used ongoing NTD MS registry ( 13 ), there is a steady increase of information (~1.3% increase of patient numbers per quarter in the year 2020, data not shown here). Therefore, PHREND® is updated on a quarterly basis and prediction quality over time is monitored.…”
Section: Methodsmentioning
“…The presentation needs to integrate options to reflect upcoming questions in the shared decision process regarding their impact on choices between DMTs. PHREND® can be used as a standalone solution with clinical data being entered manually per patient or as part of the patient management platform DESTINY ® ( 13 ) with automated data transfers.…”
Section: Methodsmentioning